Drug Information

Drug General Information
Drug ID
D0G2EQ
Former ID
DNC009437
Drug Name
(1S,2S)-N-Arachidonoylcyclopropanolamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530070]
Structure
Download
2D MOL

3D MOL
Formula
C23H37NO2
Canonical SMILES
CCCCCC=CCC=CCC=CCC=CCCCC(=O)NC1CC1O
InChI
1S/C23H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23(26)24-21-20-22(21)25/h6-7,9-10,12-13,15-16,21-22,25H,2-5,8,11,14,17-20H2,1H3,(H,24,26)/b7-6-,10-9-,13-12-,16-15-/t21-,22-/m0/s1
InChIKey
LZHCSJBKBARIFQ-NILUWUTCSA-N
PubChem Compound ID
42617990
Target and Pathway
Target(s) Cannabinoid receptor 2 Target Info Inhibitor [530070]
Cannabinoid receptor 1 Target Info Inhibitor [530070]
KEGG Pathway Neuroactive ligand-receptor interactionhsa04015:Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling eventsR-HSA-373076:Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like
BDNF signaling pathway
GPCR downstream signaling
GPCRs, Other
References
Ref 530070J Med Chem. 2009 May 14;52(9):3001-9.Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes.
Ref 530070J Med Chem. 2009 May 14;52(9):3001-9.Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.